By assessing CXCR4 expression as compared to an isotype control antibody (gating strategy depicted in Supplementary Fig S1), we identified 14 of 25 patients (56%) with CXCR4-positive MM. The gene discussed is CXCR4; the disease is Miyoshi myopathy.